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M.R. Kapma,1 E.L.G. Verhoeven,1* I.F.J. Tielliu,1 C.J.A.M. Zeebregts,1 T.R. Prins,2
B. Van der Heij1 and J.J.A.M. Van den Dungen1Departments of 1Surgery and 2Radiology, University Hospital of Groningen, Groningen, The NetherlandsObjectives. To analyse the results of emergency endovascular aneurysm repair (eEVAR) for acute abdominal aortic
aneurysms (AAA), in comparison to open repair, and to evaluate suitability and application rate.
Patients and methods. All patients treated for an acute AAA between January 1998 and August 2004 were included. The
primary outcome measure was in-hospital mortality. Secondary outcome measures were procedure time, intra-operative
blood loss, transfusion requirement, intensive care unit, and hospital length of stay. Suitability and application rate for
eEVAR were assessed in a subgroup of patients, from January 2003.
Results. A total of 253 patients were treated. eEVAR was performed in 40 patients, 5 (13%) died in-hospital. Open repair
was performed in 213 patients, 64 (30%) died in-hospital. Secondary outcome measures were all significantly improved in
the eEVAR subgroup.
From January 2003, 56 patients were treated. Of the 44 (79%) patients who were evaluated for eEVAR, 16 (36%) patients
were anatomically suitable. Eventually, 15 out of the 56 (27%) patients were treated by eEVAR.
Conclusion. The results of eEVAR in a selected group of patients are promising, but suitability and application rate were
low.Keywords: Abdominal aortic aneurysm; Rupture; Endovascular; Suitability; Mortality.Introduction
Open surgery for ruptured abdominal aortic aneur-
ysm (AAA) still carries a high mortality, in a range
between 35 and 70% among the patients who reach the
hospital alive.1–7 Despite advances in technology and
critical care, this mortality rate has remained
unchanged for the last two decades.8
The first report of emergency endovascular aneur-
ysm repair (eEVAR) was published in 1994.9 Several
cohort studies followed with promising initial
results.10–17 Possible advantages of eEVAR are avoid-
ance of both laparotomy and general anaesthesia.
General anaesthesia has the disadvantage of deeper
hypotension through loss of sympathetic nervous
system compensation of hypovolaemia.18 Positioning
the aortic clamp during urgent laparotomy can cause
iatrogenic injury of adjacent veins, including the cavaling author. E.L.G. Verhoeven, MD, Division of Vascu-
epartment of Surgery, University Hospital of Gronin-
lein 1, P.O. Box 30.001, 9700 RB Groningen, The
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emerged with eEVAR is the principle of ‘hypotensive
haemostasis’. Many now believe that patients with a
ruptured aneurysm should not be resuscitated aggres-
sively, to prevent further rupture.
An obstacle to the widespread use of eEVAR is the
need for an endovascular team to be available at all
times. In addition, a subgroup of patients with
ruptured aneurysm cannot tolerate any delay of
treatment, such as that caused by the pre-operative
CT-scan needed for eEVAR.
This study reports a cohort of patients treated for an
acute AAA in a single university hospital, and
compares open repair and eEVAR mortality rates. In
addition, suitability and application rate for eEVAR
are assessed.Patients and MethodsEvaluation of the patient
On arrival at the emergency department patientsEur J Vasc Endovasc Surg 29, 510–515 (2005)
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Emergency EVAR 511underwent immediate ultra-sound scanning to con-
firm the diagnosis of acute AAA, except in those cases
in which the AAA was clearly palpable. All patients
who were hemodynamically stable enough underwent
immediate CT-scanning. In cases of hemodynamic
instability, the attending vascular surgeon had the
option to send the patient for immediate open repair.
Evaluation for eEVAR was performed by the endo-
vascular team directly following the CT-scan. Ana-
tomical suitability for eEVAR was evaluated according
to guidelines for elective EVAR including proximal
neck length O1.5 cm with less than 60 degrees
angulation, and access vessels large enough to
accommodate the introducer systems. Several bifur-
cated modular devices were used including Van-
guardw (Boston Scientific, Natick, MA, USA), Talentw
(Medtronic World Medical, Sunrise, FL, USA), Zenith
Tri-Fabw (William A. Cook Australia, Brisbane, Aus-
tralia), and Excluderw (W.L. Gore and Associates,
Flagstaff, AZ, USA) devices. In one case, an aorta-uni-
iliacal (AUI) device was used (Zenithw, William A.
Cook Australia, Brisbane, Australia).Operative technique and anaesthesia
Every procedure was performed in an operating room
using a mobile image intensifier (OEC 9800, GE
medical Systems, Milwaukee, WI, USA) with digital
subtraction angiography and video output. Vascular
access was obtained via bilateral surgical cut-down of
the common femoral arteries. Local anaesthesia was
achieved with 1% lidocaine with epinephrine (maxi-
mum dose of 4 mg/kg). All patients were monitored
non-invasively by the anaesthetist. The goal was to
maintain patients awake, co-operative, and able to
control their breath. Intravenous (i.v.) sedation was
used sparingly and only to achieve patient comfort. In
case the patient suffered from pain, fentanyl, 50–
150 mgs were given i.v. When indicated, the patient
was sedated with midazolam 0.05–0.2 mg/kg i.v. or
with propofol 25–75 mg/kg/min i.v. In some cases
remifentanyl was administered in a dose of
0.1 mg/kg/min. To accurately deploy the stent-graft
close to the renal arteries, intraoperative angiography
was used, but only after the main delivery sheath had
been advanced to the level of the first lumbar vertebra.
As soon as possible, the empty sheath of the main
device was removed (i.e. after full deployment and
ballooning ipsilaterally), and purse strings, tightened
with a Rummel’s tourniquet, were used for hemostasis
around the guide wire. This was left in place until the
contra-lateral limb of the stent-graft was delivered and
a completion angiogram obtained. After surgery,patients were cared for in the recovery room or
transferred to the intensive care unit (ICU), depending
on their condition.Study cohorts
Cohort I: peri-operative outcome and mortality
All consecutive patients treated for an acute infra-
renal AAA between January 1998 and August 2004
were included in this study. eEVAR was considered
only when an endovascular team was present and a
sufficient stock of devices available. From 2003 on, a
policy was adopted of preferential eEVAR treatment
for acute AAA.
Primary endpoint in this study was hospital
mortality. Secondary endpoints were peri-operative
outcome measures including procedure time, intra-
operative blood loss, need for blood transfusion
(number of packed cells) during hospital stay, ICU
length of stay, and hospital length of stay.
Cohort II: suitability and application rate
To evaluate suitability and application rate of eEVAR,
a cohort of patients presenting from January 2003 to
August 2004 was studied. The following data were
registered: number of patients reaching the hospital
alive, number of patients not receiving treatment,
number of patients evaluated for eEVAR, anatomical
suitability, and number of patients treated by eEVAR.Definitions
Acute AAA was defined as any AAA requiring
treatment within 24 h. Differentiation was made
between acute ruptured AAA (RAAA) and acute
non-ruptured AAA (nRAAA). An acute AAA was
only classified as RAAA in the presence of a retro-
peritoneal hematoma on the preoperative CT-scan in
the eEVAR group, or at laparotomy in the open repair
group. All other acute AAA were classified as acute
nRAAA.
Suitability for eEVAR was defined as the percentage
of patients with an acute AAA evaluated by CT-scan,
who were anatomically candidates for eEVAR. Appli-
cation rate was defined as the percentage of patients
treated with eEVAR out of the total treated group.Statistics
Patient characteristics, operation data and peri-oper-
ative outcome data were recorded in a database with
use of SPSS 10.0 data editor (Microsoft Corporation,Eur J Vasc Endovasc Surg Vol 29, May 2005
M. R. Kapma et al.512USA). Statistical analysis was performed using Stu-
dent t-test (normal distribution) and Mann–Whitney U
test (skewed distributed) for continuous variables and
Fisher’s exact test for categorical variables. Differences
were considered significant with p!0.05.ResultsCohort I: peri-operative outcome and mortality
A total of 262 patients with an acute AAA were
admitted to the emergency department. Nine (3%)
patients were not treated because of old age combined
with co-morbidity, leaving 253 patients in the study
group. Patient characteristics of the eEVAR and open
repair treated groups are summarised in Table 1.
Differences between the groups included older age in
the eEVAR group and more RAAA in the open repair
group.
The hemodynamic condition of the eEVAR patients
was summarised in Table 2. The following devices
were used in the eEVAR group: 30 Zenith Tri-Fabw, one
Zenith AUIw, three Excluderw, three Vanguardw, and
two Talentw devices. Local anaesthesia was used in 33
(83%) patients. Four (10%) patients were treated underTable 1. Characteristics and peri-operative outcome of the open
and eEVAR group




Male 185 (87%) 37 (92%) 0.434
Female 28 (13%) 3 (8%)
Age (years)
Median 71 75 0.042
Range 48–87 54–87
Ruptured or non-ruptured
Ruptured 172 (81%) 25 (62%) 0.021
Non-rup-
tured
41 (19%) 15 (38%)
Procedure time (min)
Median 180 110 !0.001
Range 30–375 55–240
Blood loss (ml)
Median 3500 200 !0.001
Range 200–26000 50–2800
Transfusion need (pc)
Median 6 0 !0.001
Range 0–65 0–13
Hospital length of stay (days)
Median 12 5 !0.001
Range 1–102 1–22
ICU stay (h)
Median 48 0 !0.001
Range 0–2328 0–336
Open, open repair; eEVAR, emergency endovascular aneurysm
repair; pc, units of packed cells; ICU, intensive care unit.
Eur J Vasc Endovasc Surg Vol 29, May 2005general anaesthesia and three (7%) patients required
conversion from local to general anaesthesia.
For treated patients, overall in-hospital mortality
was 69/253 (27%). Mortality was significantly lower in
the eEVAR group compared to the open group (eEVAR
13% vs. open 30%, PZ0.021). When only RAAAs were
considered, there was no difference in mortality
between open repair and eEVAR (Table 3). Only a
minority of patients presented with nRAAA and no
difference between the treatment groups was evident
(Table 3). Procedure time, blood loss, transfusion need,
ICU length of stay, and hospital length of stay were all
significantly lower in the eEVAR group (p!0.001)
(Table 1).
There were three intra-operative technical problems
requiring open surgery. One patient was converted to
open repair because of insufficient access. This became
evident after cut-down of the common femoral arteries
and a try-out with a 12 French sheath. Immediately
open repair was undertaken. A second patient with an
aorto-iliac aneurysm including both common iliac
arteries underwent a laparotomy to ligate both
hypogastric arteries after eEVAR. Finally, a third
patient underwent a laparotomy at the end of the
procedure because of abdominal compartment syn-
drome, a very large retroperitoneal hematoma was
evacuated.
Among the 40 patients who underwent eEVAR, five
(13%) patients died. Two of them were patients who
needed additional open surgery as mentioned above.
The patient who needed conversion to open repair
developed ischaemic colitis and died 12 days later of
multiple organ failure. An 83-year-old patient needing
laparotomy to ligate both hypogastric arteries died at
the end of the procedure from hypovolemic shock. A
third patient died 3 days after successful aneurysm
exclusion due to cardiac failure. A fourth patient
underwent acute aorto-uni-iliac stent-grafting, fol-
lowed by femoro-femoral crossover, requiring conver-
sion from local to general anaesthesia. He died 12 days
post-operatively due to respiratory insufficiency. The
fifth patient in the eEVAR group died 1 h after the
procedure, most likely due to hypovolemic shock
following a lengthy procedure.Cohort II: suitability and application rate
Between January 2003 and August 2004, 59 patients
were admitted to our hospital with an acute AAA (Fig.
1). Three patients were not treated due to old age and
co-morbidity. The remaining 56 (95%) patients were
treated. From this group, 44 (79%) patients were
evaluated for eEVAR by CT-scan. Twelve (21%)
Table 2. Systolic blood pressure of the eEVAR group on arrival at the emergency department
Systolic BP (mmHg) RAAA Mortality nRAAA Mortality
!70 7 4 0 0
70–100 15 0 0 0
O100 3 1 15 0
BP, bloodpressure; RAAA, ruptured abdominal aortic aneurysm; nRAAA, non-ruptured abdominal aortic aneurysm.
Emergency EVAR 513patients were not evaluated for eEVAR, because they
were too shocked (nZ8), or because no endovascular
team was available (nZ4). Of the 44 evaluated
patients, 28 (64%) patients were considered unsuitable
for eEVAR for the reasons described in Table 4. Sixteen
patients (suitability 16/44 or 36%) were considered
anatomically suitable for eEVAR. One of these 16
patients received open repair because of suspicion of a
mycotic aneurysm. This diagnosis was based on
clinical presentation, infectious parameters, CT-find-
ings, and a positive blood culture with haemophilus
influenzae. Fifteen patients were treated by eEVAR
(application rate 15/56 or 27%).Discussion
The overall mortality in this study (27%) compares
well with published results, particularly if we take into
account that 95% of the patients with an acute AAA
were treated.1–8 The eEVAR mortality rate (13%) was
in accord with previous studies, reporting mortality
rates ranging from 9 to 19%.11–16 Mortality of the
nRAAA subgroup treated by open repair (17%) was
high, but similar to other reports, with mortality rates
of 9–18%.19–22 The deceased patients with a nRAAA
(nZ7) had extensive co-morbidity, and three were
more than 80 years old. In addition, the open group
was classified strictly: only a positive report of a
retroperitoneal hematoma or free rupture was
accepted as RAAA.
It is difficult to attribute a positive effect of eEVAR
on the overall mortality, because eEVAR was only used
in a small proportion of the entire cohort. The open
and eEVAR group are not comparable due to a
difference in ratio of nRAAA/RAAA. In addition,
there is bias in favour of the eEVAR group due to
anatomical, and hemodynamic selection. Several
patients were not evaluated due to hemodynamicTable 3. Mortality of acute ruptured and acute non-ruptured AAA p
Open
n Mortality
RAAA 172 57 (33%)
NRAAA 41 7 (17%)
Total 213 64 (30%)
RAAA, ruptured abdominal aortic aneurysm; nRAAA, non-ruptured ainstability, and treated by open repair. However, four
out of the five patients who died after eEVAR, were
hemodynamically unstable with a blood pressure of!
70 mmHg on arrival, as shown in Table 2. Never-
theless, the results of eEVAR in the nRAAA group are
promising and the results in the RAAA group
acceptable.
There are lessons to be learned from the eEVAR
group. The results of eEVAR include one patient who
died after conversion to an open repair. At the
beginning of the endovascular procedure, access
proved impossible. Open repair was carried out,
with an estimated delay of about 30 min. The patient
died 12 days later from multiple organ failure. This
mortality was allocated to the eEVAR group, based on
the intention-to-treat principle. In a second patient,
with an aorto-iliac aneurysm, aged 83 and in a poor
hemodynamic condition, eEVAR was attempted, but
the patient died at the end of the procedure. In
retrospect, this patient with a large bilateral aorto-iliac
aneurysm was not a good candidate. Currently, this
type of aneurysm is excluded from eEVAR in unstable
patients, because quick sealing is not possible, and
additional techniques are required to seal the internal
iliac artery back flow. A bell-bottom technique is a
good option, but will treat common iliac artery
aneurysms only up to 22 mm in diameter.
A clear advantage of eEVAR over open repair was
demonstrated in terms of procedure time, blood loss,
blood transfusion requirements, ICU length of stay,
and length of hospital stay. These advantages are in
accord with the literature on elective EVAR and they
will contribute to cost-effectiveness of the eEVAR.23,24
Logistics do play an important role in the treatment
of acute AAA. In our institution, we operate a warning
system through the ambulance services. This triggers a
series of actions: CT-scan and operating theatre are
made available before arrival of the patient, and a team
consisting of a vascular surgeon, a radiologist, and anatients
EVAR P
n Mortality
25 5 (20%) 0.25
15 0 0.17
40 5 (13%) 0.02
bdominal aortic aneurysm.
Eur J Vasc Endovasc Surg Vol 29, May 2005
Fig. 1. Patients included from January 2003 to August 2004.
M. R. Kapma et al.514anaesthetist are present at the emergency department
before arrival of the patient. In addition, experienced
theatre nurses and radiology technicians are present
day and night. Nevertheless, it is difficult to have an
experienced endovascular team available at all times.
The cut-off point of January 2003 for the suitability
and application rate assessment was chosen, because it
marks our policy shift towards preferential treatment
of acute AAA by eEVAR. Previous to this time, we did
not have sufficient stock of devices available at all
times, particularly on the two occasions when a
stocked device was withdrawn from the market.
Although we used and still use different devices inTable 4. Contraindications to eEVAR
Features Number of patients (n)




Aorto-iliac aneurysm 8 (29%)
No access 1 (4%)
Combination 6 (21%)
Total 28
Eur J Vasc Endovasc Surg Vol 29, May 2005the elective setting, it is impossible to have them all on
stock.
Evaluation for eEVAR occurred in 79% of the
patients with an acute AAA. Twenty-one percent of
the patients were not evaluated: eight (14%) patients
because of hemodynamic instability, and four (7%)
patients because an endovascular team was not
available immediately.
Studies of untreated RAAA patients showed that
most patients (87%) admitted to the hospital, died only
after more than 2 h. The authors concluded that most
patients with a RAAA are stable enough to undergo
evaluation for eEVAR.19,20 As in our study, the
literature reports that 85–90% of patients with an
acute AAA are stable enough to allow delay of
treatment and warrant evaluation by CT-scan. Enhan-
cing hemodynamic stability by inserting and inflating
an aortic balloon in the remaining group of patients,
who are too unstable, is another possibility, but a
disadvantage is the worse quality of the intra-
operative angiography due to a lack of flow. The
logistic problem regarding the non-availability of an
endovascular team could be solved with increasing
experience.
In our study, we found an anatomical suitability of
36%. This is accord with the literature on CT-scan
studies, reporting anatomical suitability between 20
and 45%.25–27 The application rate was low (27%).
Recent clinical studies have reported an application
rate between 20 and 80%.11–16,28 Taking the suitability
studies into account, this wide range in application
rate might be explained by a more liberal application
of inclusion criteria, or by pre-selection due to a
different referral pattern from surrounding hospitals.
With regard to the inclusion criteria, one can argue
whether a 5–15 mm neck should be a contra-indication
for eEVAR. In the elective setting, initial results of
stent-grafting in such 5–15 mm necks have been
positive.29 Obviously, long-term results have to be
awaited to change the inclusion criteria in the elective
setting. In the acute setting, the goal is to save the
patients’ life and, therefore, a shorter neck might be
acceptable. In our hospital, we have started a
prospective trial of eEVAR, in which we accept some
shorter necks. With regard to pre-selection, we have
not yet adopted a policy of accepting stable acute AAA
from other hospitals. Our policy is that patients with
an acute AAA should not be transferred unless there is
no treatment option in the local hospital. In our series,
seven of the 59 patients with an acute AAA were
referred from other hospitals, because urgent treat-
ment was technically impossible in the local hospital
due to the non-availability of a vascular surgeon, or an
intensive care unit facility. Only two out of these seven
Emergency EVAR 515patients were treated with eEVAR (one survived, one
died).Conclusion
Overall mortality of acute AAA was low (27%).
Mortality in the eEVAR group was lower than in the
open group, but eEVAR was only used in a small
proportion of selected patients. eEVAR was associated
with a shorter procedure time, a shorter hospital and
intensive care unit length of stay, and lower blood loss
and transfusion requirements. Suitability and appli-
cation rate of eEVAR for acute AAA were 36 and 27%,
respectively.References
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